218 related articles for article (PubMed ID: 18369692)
21. Overexpression of Programmed Death-Ligand 1 Receptor mRNA as an Independent Negative Prognostic Factor for Triple Negative Breast Cancer.
Purwanto I; Heriyanto DS; Ghozali A; Widodo I; Dwiprahasto I; Aryandono T; Haryana SM
World J Oncol; 2020 Oct; 11(5):216-222. PubMed ID: 33117465
[TBL] [Abstract][Full Text] [Related]
22. Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4.
Navarrete-Bernal MGC; Cervantes-Badillo MG; Martínez-Herrera JF; Lara-Torres CO; Gerson-Cwilich R; Zentella-Dehesa A; Ibarra-Sánchez MJ; Esparza-López J; Montesinos JJ; Cortés-Morales VA; Osorio-Pérez D; Villegas-Osorno DA; Reyes-Sánchez E; Salazar-Sojo P; Tallabs-Utrilla LF; Romero-Córdoba S; Rocha-Zavaleta L
Front Oncol; 2020; 10():1206. PubMed ID: 32850353
[TBL] [Abstract][Full Text] [Related]
23. Circulating extracellular vesicles from patients with breast cancer enhance migration and invasion via a Src‑dependent pathway in MDA‑MB‑231 breast cancer cells.
Ramírez-Ricardo J; Leal-Orta E; Martínez-Baeza E; Ortiz-Mendoza C; Breton-Mora F; Herrera-Torres A; Elizalde-Acosta I; Cortes-Reynosa P; Thompson-Bonilla R; Perez Salazar E
Mol Med Rep; 2020 Sep; 22(3):1932-1948. PubMed ID: 32582965
[TBL] [Abstract][Full Text] [Related]
24. Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients.
Wen S; Manuel L; Doolan M; Westhuyzen J; Shakespeare TP; Aherne NJ
Breast Cancer (Dove Med Press); 2020; 12():27-35. PubMed ID: 32184654
[TBL] [Abstract][Full Text] [Related]
25. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351
[TBL] [Abstract][Full Text] [Related]
26. The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer.
Li Y; Zhou Y; Mao F; Guan J; Lin Y; Wang X; Zhang Y; Zhang X; Shen S; Sun Q
Sci Rep; 2019 Jul; 9(1):10158. PubMed ID: 31308467
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.
Ozawa PMM; Alkhilaiwi F; Cavalli IJ; Malheiros D; de Souza Fonseca Ribeiro EM; Cavalli LR
Breast Cancer Res Treat; 2018 Dec; 172(3):713-723. PubMed ID: 30173296
[TBL] [Abstract][Full Text] [Related]
28. Chondroitin sulfate-mediated N-cadherin/β-catenin signaling is associated with basal-like breast cancer cell invasion.
Nadanaka S; Kinouchi H; Kitagawa H
J Biol Chem; 2018 Jan; 293(2):444-465. PubMed ID: 29183998
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis.
Cocciolone V; Cannita K; Calandrella ML; Ricevuto E; Baldi PL; Sidoni T; Irelli A; Paradisi S; Pizzorno L; Resta V; Bafile A; Alesse E; Tessitore A; Ficorella C
Oncotarget; 2017 Sep; 8(42):72031-72043. PubMed ID: 29069766
[TBL] [Abstract][Full Text] [Related]
30. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.
Saraiva DP; Guadalupe Cabral M; Jacinto A; Braga S
ESMO Open; 2017; 2(4):e000208. PubMed ID: 29018573
[TBL] [Abstract][Full Text] [Related]
31. Role of postmastectomy radiotherapy in early-stage (T1-2N0-1M0) triple-negative breast cancer: a systematic review.
Chen F; Pu F
Onco Targets Ther; 2017; 10():2009-2016. PubMed ID: 28435291
[TBL] [Abstract][Full Text] [Related]
32. The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience.
Eralp Y; Kılıç L; Alço G; Başaran G; Doğan M; Dinçol D; Demirci S; İçli F; Onur H; Saip P; Haydaroğlu A
J Breast Health; 2014 Oct; 10(4):209-215. PubMed ID: 28331673
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of node status in different breast cancer subtypes.
Yang ZJ; Yu Y; Hou XW; Chi JR; Ge J; Wang X; Cao XC
Oncotarget; 2017 Jan; 8(3):4563-4571. PubMed ID: 27999188
[TBL] [Abstract][Full Text] [Related]
35. Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women.
Prasad S; Efird JT; James SE; Walker PR; Zagar TM; Biswas T
Springerplus; 2016; 5(1):756. PubMed ID: 27386241
[TBL] [Abstract][Full Text] [Related]
36. Effect of nodal status on clinical outcomes of triple-negative breast cancer: a population-based study using the SEER 18 database.
Wang XX; Jiang YZ; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Jul; 7(29):46636-46645. PubMed ID: 27203673
[TBL] [Abstract][Full Text] [Related]
37. Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.
Agrawal A; Ziolkowski P; Grzebieniak Z; Jelen M; Bobinski P; Agrawal S
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):550-5. PubMed ID: 26230371
[TBL] [Abstract][Full Text] [Related]
38. SERUM THYROTROPIN CONCENTRATIONS ARE NOT PREDICTIVE OF AGGRESSIVE BREAST CANCER BIOLOGY IN EUTHYROID INDIVIDUALS.
Villa NM; Li N; Yeh MW; Hurvitz SA; Dawson NA; Leung AM
Endocr Pract; 2015 Sep; 21(9):1040-5. PubMed ID: 26121443
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological Characteristics of Triple-negative Breast Cancers in the Northeast Region of Turkey.
Yıldız B; Fidan E; Ozdemir F; Sezen O; Kavgacı H; Aydın F
Balkan Med J; 2014 Jun; 31(2):126-31. PubMed ID: 25207183
[TBL] [Abstract][Full Text] [Related]
40. Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients.
Rambau P; Masalu N; Jackson K; Chalya P; Serra P; Bravaccini S
BMC Res Notes; 2014 Jun; 7():399. PubMed ID: 24964871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
